Innoviva, Inc.
DE ˙ DB ˙ US45781M1018
19,20 € ↑0,70 (3,78%)
2026-06-04
DEL PRIS
SecurityDE:HVE / Innoviva, Inc.
InstitutionMorgan Stanley
Latest Disclosed Ownership1,310,750 shares
Latest Disclosed Value $ 30,540,495
Morgan Stanley reports 7.61% decrease in ownership of HVE / Innoviva, Inc.

On May 15, 2026 - Morgan Stanley filed a 13F-HR form disclosing ownership of 1,310,750 shares of Innoviva, Inc. (DE:HVE) valued at $26,215,000 USD as of March 31, 2026. The entity filed a previous 13F-HR/A on May 27, 2026 disclosing 1,418,739 shares of Innoviva, Inc.. This represents a change in shares of -7.61% during the quarter. The current value of the position is $25,166,400 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F INNOVIVA COM 45781M101 1,310,750 -107,989 -7.61 30,540 7.69 0.0018
2026-05-27 2025-12-31 13F/A-1 INNOVIVA COM 45781M101 1,418,739 -6,874 -0.48 28,361 9.01 0.0017
2026-02-13 2025-12-31 13F INNOVIVA COM 45781M101 1,418,739 -6,874 28,361 0.0017
2026-05-27 2025-09-30 13F/A-1 INNOVIVA COM 45781M101 1,425,613 -203,592 -12.50 26,017 -20.51 0.0016
2025-11-14 2025-09-30 13F INNOVIVA COM 45781M101 1,425,613 -203,592 26,017 0.0016
2025-08-15 2025-06-30 13F INNOVIVA COM 45781M101 1,629,205 547,547 50.62 32,731 66.90 0.0021
2025-05-15 2025-03-31 13F INNOVIVA COM 45781M101 1,081,658 -6,887 -0.63 19,610 3.83 0.0014
2025-05-15 2024-12-31 13F/A-1 INNOVIVA COM 45781M101 1,088,545 86,180 8.60 18,886 -2.42 0.0013
2025-02-14 2024-12-31 13F INNOVIVA COM 45781M101 1,088,545 86,180 18,886 0.0013
2025-05-14 2024-09-30 13F/A-2 INNOVIVA COM 45781M101 1,002,365 69,415 7.44 19,356 26.50 0.0014
2025-02-14 2024-09-30 13F/A-1 INNOVIVA COM 45781M101 1,002,365 69,415 19,356 0.0014
2024-11-14 2024-09-30 13F INNOVIVA COM 45781M101 1,002,365 69,415 19,356 0.0002
2025-05-14 2024-06-30 13F/A-2 INNOVIVA COM 45781M101 932,950 -247,453 -20.96 15,300 -14.95 0.0012
2024-10-17 2024-06-30 13F/A-1 INNOVIVA COM 45781M101 932,950 -247,453 15,300 0.0012
2024-08-14 2024-06-30 13F INNOVIVA COM 45781M101 932,950 -247,453 15,300 0.0012
2024-10-17 2024-03-31 13F/A-2 INNOVIVA COM 45781M101 1,180,403 -936,754 -44.25 17,989 -47.03 0.0014
2024-08-16 2024-03-31 13F/A-1 INNOVIVA COM 45781M101 1,180,403 -936,754 17,989 0.0002
2024-05-15 2024-03-31 13F INNOVIVA COM 45781M101 1,180,403 -936,754 17,989 0.0014
2024-08-16 2023-12-31 13F/A-1 INNOVIVA COM 45781M101 2,117,157 2,078,587 5,389.13 33,959 32,869.90 0.0030
2024-08-16 2023-12-31 13F/A-1 THESEUS PHARMACEUTICALS COM 88369M101 90,791 368
2024-02-13 2023-12-31 13F THESEUS PHARMACEUTICALS COM 88369M101 90,791 52,221 368 0.0000
2024-02-13 2023-12-31 13F INNOVIVA COM 45781M101 2,117,157 1,278,776 33,959 0.0004
2023-11-15 2023-09-30 13F THESEUS PHARMACEUTICALS COM 88369M101 38,570 -1,407 -3.52 104 -72.31 0.0000
2023-11-15 2023-09-30 13F INNOVIVA COM 45781M101 838,381 83,750 10,891 0.0011
2023-08-14 2023-06-30 13F THESEUS PHARMACEUTICALS COM 88369M101 39,977 -1,910 -4.56 373 0.27 0.0000
2023-08-14 2023-06-30 13F INNOVIVA COM 45781M101 754,631 -283,722 9,606 0.0009
2023-05-15 2023-03-31 13F THESEUS PHARMACEUTICALS COM 88369M101 41,887 30,409 264.93 372 550.88 0.0000
2023-05-15 2023-03-31 13F INNOVIVA COM 45781M101 1,038,353 -325,243 11,681 0.0013
2023-02-14 2022-12-31 13F THESEUS PHARMACEUTICALS COM 88369M101 11,478 2,721 31.07 57 11.76 0.0000
2023-02-14 2022-12-31 13F INNOVIVA COM 45781M101 1,363,596 -588,170 18,068 0.0021
2022-11-14 2022-09-30 13F THESEUS PHARMACEUTICALS COM 88369M101 8,757 -3,876 -30.68 51 -27.14 0.0000
2022-11-14 2022-09-30 13F INNOVIVA COM 45781M101 1,951,766 181,903 22,660 0.0031
2022-10-27 2022-06-30 13F/A-1 THESEUS PHARMACEUTICALS COM 88369M101 12,633 2,985 30.94 70 -36.94 0.0000
2022-10-27 2022-06-30 13F/A-1 INNOVIVA COM 45781M101 1,769,863 244,756 26,124 0.0034
2022-08-15 2022-06-30 13F THESEUS PHARMACEUTICALS COM 88369M101 12,633 2,985 70 0.0000
2022-08-15 2022-06-30 13F INNOVIVA COM 45781M101 1,769,863 244,756 26,124 0.0007
2022-10-27 2022-03-31 13F/A-1 THESEUS PHARMACEUTICALS COM 88369M101 9,648 -31 -0.32 111 -9.76 0.0000
2022-10-27 2022-03-31 13F/A-1 INNOVIVA COM 45781M101 1,525,107 1,072,828 29,511 0.0040
2022-05-13 2022-03-31 13F THESEUS PHARMACEUTICALS COM 88369M101 9,648 -31 111 0.0000
2022-05-13 2022-03-31 13F INNOVIVA COM 45781M101 1,525,107 1,072,828 29,511 0.0040
2022-02-14 2021-12-31 13F THESEUS PHARMACEUTICALS COM 88369M101 9,679 -889,284 -98.92 123 -99.18 0.0000
2022-02-14 2021-12-31 13F INNOVIVA COM 45781M101 452,279 -446,684 7,802 0.0010
2021-11-15 2021-09-30 13F INNOVIVA COM 45781M101 898,963 171,290 23.54 15,019 53.91 0.0020
2021-08-23 2021-06-30 13F/A-1 INNOVIVA COM 45781M101 727,673 48,777 7.18 9,758 20.26 0.0013
2021-08-16 2021-06-30 13F INNOVIVA COM 45781M101 727,673 48,777 9,758 0.0003
2021-05-17 2021-03-31 13F INNOVIVA COM 45781M101 678,896 45,152 7.12 8,114 3.32 0.0012
2021-02-16 2020-12-31 13F INNOVIVA COM 45781M101 633,744 -317,459 -33.37 7,853 -21.00 0.0012
2020-11-13 2020-09-30 13F INNOVIVA COM 45781M101 951,203 401,259 72.96 9,940 29.29 0.0019
2020-08-14 2020-06-30 13F INNOVIVA COM 45781M101 549,944 353,904 180.53 7,688 233.68 0.0017
2020-05-26 2020-03-31 13F/A-1 INNOVIVA COM 45781M101 196,040 -296,322 -60.18 2,304 -66.95 0.0006
2020-05-15 2020-03-31 13F INNOVIVA COM 45781M101 196,040 -296,322 2,304 176.9952
2020-02-14 2019-12-31 13F INNOVIVA COM 45781M101 492,362 155,261 46.06 6,971 96.20 0.0016
2019-11-14 2019-09-30 13F INNOVIVA COM 45781M101 337,101 -179,532 -34.75 3,553 -52.77 0.0009
2019-08-14 2019-06-30 13F INNOVIVA COM 45781M101 516,633 425,318 465.77 7,522 487.20 0.0020
2019-05-15 2019-03-31 13F INNOVIVA COM 45781M101 91,315 -278,065 -75.28 1,281 -80.12 0.0004
2019-02-14 2018-12-31 13F INNOVIVA COM 45781M101 369,380 -322,034 -46.58 6,444 -38.84 0.0019
2019-04-23 2018-09-30 13F/A-2 INNOVIVA COM 45781M101 691,414 325,608 89.01 10,537 108.69 0.0026
2018-11-20 2018-09-30 13F/A-1 INNOVIVA COM 45781M101 691,414 0 10,537 0.0026
2018-11-14 2018-09-30 13F INNOVIVA COM 45781M101 691,414 325,608 10,537
2019-04-23 2018-06-30 13F/A-1 INNOVIVA COM 45781M101 365,806 -310,494 -45.91 5,049 -55.22 0.0014
2018-08-14 2018-06-30 13F INNOVIVA COM 45781M101 365,806 -310,494 5,049
2019-04-23 2018-03-31 13F/A-1 INNOVIVA COM 45781M101 676,300 -145,824 -17.74 11,274 -3.35 0.0031
2018-05-14 2018-03-31 13F INNOVIVA COM 45781M101 676,300 -145,824 11,274
2019-04-23 2017-12-31 13F/A-1 INNOVIVA COM 45781M101 822,124 52,385 6.81 11,665 7.32 0.0032
2018-02-14 2017-12-31 13F INNOVIVA COM 45781M101 822,124 52,385 11,665
2017-11-14 2017-09-30 13F INNOVIVA COM 45781M101 769,739 461,098 149.40 10,869 175.16 0.0033
2017-08-11 2017-06-30 13F INNOVIVA COM 45781M101 308,641 -255,786 -45.32 3,950 -49.40 0.0012
2017-05-22 2017-03-31 13F/A-1 INNOVIVA COM 45781M101 564,427 270,824 92.24 7,807 148.55 0.0024
2017-05-12 2017-03-31 13F INNOVIVA COM 45781M101 564,427 7,807
2017-02-22 2016-12-31 13F/A-1 INNOVIVA COM 45781M101 293,603 251,499 597.33 3,141 579.87 0.0010
2017-02-13 2016-12-31 13F INNOVIVA COM 45781M101 293,603 3,141
2016-11-10 2016-09-30 13F INNOVIVA COM 45781M101 42,104 -39,355 -48.31 462 -46.15 0.0002
2016-08-12 2016-06-30 13F INNOVIVA COM 45781M101 81,459 53,415 190.47 858 143.75 0.0003
2016-05-12 2016-03-31 13F INNOVIVA COM 45781M101 28,044 -28,740 -50.61 352 -41.24 0.0001
2016-02-09 2015-12-31 13F THERAVANCE COM 88338T104 56,784 1,020 1.83 599 49.75 0.0002
2016-02-08 2015-09-30 13F/A-1 THERAVANCE COM 88338T104 55,764 -8,914 -13.78 400 -65.78 0.0001
2015-11-09 2015-09-30 13F THERAVANCE COM 88338T104 55,764 400
2015-08-12 2015-06-30 13F THERAVANCE COM 88338T104 64,678 -181,079 -73.68 1,169 -69.74 0.0004
2015-05-14 2015-03-31 13F THERAVANCE COM 88338T104 245,757 174,271 243.78 3,863 281.72 0.0014
2015-02-13 2014-12-31 13F THERAVANCE COM 88338T104 71,486 7,738 12.14 1,012 -7.16 0.0004
2014-12-16 2014-09-30 13F/A-1 THERAVANCE COM 88338T104 63,748 51,492 420.14 1,090 187.60 0.0004
2014-11-14 2014-09-30 13F THERAVANCE COM 88338T104 63,748 1,090
2014-05-13 2014-03-31 13F THERAVANCE COM 88338T104 12,256 4,247 53.03 379 32.98 0.0002
2014-02-13 2013-12-31 13F THERAVANCE COM 88338T104 8,009 -3,106 -27.94 285 -37.22 0.0001
2013-11-13 2013-09-30 13F THERAVANCE COM 88338T104 11,115 -21,094 -65.49 454 -63.42 0.0002
2013-08-08 2013-06-30 13F THERAVANCE COM 88338T104 32,209 32,209 1,241 0.0006
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.